Company Filing History:
Years Active: 1983-2004
Title: Abelardo P Martinez: Innovator in Radiosensitization
Introduction
Abelardo P Martinez is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of radiosensitization, holding a total of 8 patents. His work focuses on developing novel compounds that enhance the effectiveness of radiation therapy in treating tumors.
Latest Patents
One of his latest patents involves the use of 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents. This method discloses how these compounds can specifically radiosensitize hypoxic tumor cells. Additionally, some of these compounds are identified as effective cytotoxic agents for these cells. Remarkably, they also demonstrate an unexpected ability to radiosensitize aerobic cells after or before a hypoxic incubation with the drug. This discovery provides a foundation for selectively radiosensitizing tumors while sparing normal cells. Furthermore, a novel method for preparing the 1,2,4-benzotriazine oxides is also included in his patent.
Career Highlights
Throughout his career, Abelardo has worked with esteemed organizations such as SRI International and the United States of America as represented by the Secretary of. His innovative research has positioned him as a key figure in the development of new therapeutic strategies in oncology.
Collaborations
Abelardo has collaborated with notable colleagues, including William W Lee and J Martin Brown. Their combined expertise has contributed to advancing the understanding and application of radiosensitizers in cancer treatment.
Conclusion
Abelardo P Martinez's work in the field of radiosensitization exemplifies the impact of innovative research on cancer therapy. His contributions continue to pave the way for more effective treatment options for patients.